Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease polyneuropathy
Phenotype C0011849|diabetes mellitus
Sentences 9
PubMedID- 23834220 The disruption of paranodal axo-glial junctions was found in sural nerve biopsy specimens from patients with polyneuropathy associated with type 1 diabetes mellitus, a disease caused by the autoimmune destruction of pancreatic islet cells and loss of insulin production (sima et al., 1988).
PubMedID- 21350421 [efficiency of cerebrolysin in the diabetic polyneuropathy in patients with insulin-dependency diabetes mellitus].
PubMedID- 24893232 The evidence from clinical trials shows that intensive glycemic control reduces prevalence of diabetic sensorimotor polyneuropathy in patients with type 1 diabetes mellitus, but variable outcomes are observed in patients with type 2 diabetes mellitus.
PubMedID- 22678671 [distal polyneuropathy in children with diabetes mellitus type 1].
PubMedID- 22613432 Objectives: to determine among adult patients with type-2 diabetes mellitus the proportion diagnosed with diabetic polyneuropathy (dpn) by clinical evaluation and by the hoffmann reflex (h-reflex).
PubMedID- 24174953 Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.
PubMedID- 20571999 These are the hallmarks of distal-symmetric sensory polyneuropathy (pnp), with diabetes mellitus being the most common cause in our patient population.
PubMedID- 24639928 Diabetic polyneuropathy (dpn) in patients with diabetes mellitus is a heterogeneous disease that involves various parts of the nervous system thus producing a variety of clinical symptoms.
PubMedID- 22457690 Concomitant history included pharmacologically controlled hypertension, type 2 diabetes mellitus with polyneuropathy, hypercholesterolaemia, peripheral artery disease, depression and benign prostatic hypertrophy.

Page: 1